This product has been discontinued. Please see below for alternative testing options.
Comprehensive:
* Neo Comprehensive - Myeloid Disorders
* Neo Comprehensive - Heme Cancers
Targeted:
* RUNX1/RUNX1T1 t(8;21) FISH
Additional Alternative Options:
* AML MRD Flow (Use for monitoring as FISH and NGS do not achieve MRD level sensitivity)
* Neo AML Express
If you have any questions regarding test discontinuations, please contact your local NeoGenomics Sales Representative or our Client Services team at Client.Services@NeoGenomics.com or call 866.776.5907, option 3.
RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21)
- Molecular
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Last Updated: April 17, 2026